BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 19473619)

  • 21. Rapid communication: acute renal failure associated with tenofovir: evidence of drug-induced nephrotoxicity.
    Coca S; Perazella MA
    Am J Med Sci; 2002 Dec; 324(6):342-4. PubMed ID: 12495304
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nephrotoxicity in a child with perinatal HIV on tenofovir, didanosine and lopinavir/ritonavir.
    Hussain S; Khayat A; Tolaymat A; Rathore MH
    Pediatr Nephrol; 2006 Jul; 21(7):1034-6. PubMed ID: 16773419
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Acute renal failure associated with the use of tenofovir combined with atazanavir in patients with HIV infection].
    Vallecillo-Sánchez G; Guelar-Grimberg A; González-Mena A; Knobel-Freud H
    Enferm Infecc Microbiol Clin; 2008 May; 26(5):316-7. PubMed ID: 18479652
    [No Abstract]   [Full Text] [Related]  

  • 24. Bone scintigraphy and secondary osteomalacia due to nephrotoxicity in a chronic hepatitis B patient treated with tenofovir.
    Gómez Martinez MV; Gallardo FG; Pirogova T; García-Samaniego J
    Rev Esp Med Nucl Imagen Mol; 2014; 33(2):103-5. PubMed ID: 23920225
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An investigation of the pattern of kidney injury in HIV-positive persons exposed to tenofovir disoproxil fumarate: an examination of a large population database (MHRA database).
    Danjuma MI; Mohamad-Fadzillah NH; Khoo S
    Int J STD AIDS; 2014 Mar; 25(4):273-9. PubMed ID: 24067251
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Renal adverse reactions of antiretroviral medication: proximal tubular dysfunction associated with tenofovir].
    Kuijper A; Rookmaker MB; Mudrikova T
    Ned Tijdschr Geneeskd; 2011; 155():A2249. PubMed ID: 21418698
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Editorial comment: Fanconi syndrome and tenofovir--understanding proximal tubular function.
    Fine DM
    AIDS Read; 2007 Jun; 17(6):326-7. PubMed ID: 17632941
    [No Abstract]   [Full Text] [Related]  

  • 28. Tenofovir-related nephrotoxicity: an ongoing clinical challenge.
    Foisy MM; Hughes C; Hills-Nieminen C; Singh AE; Joffe AM
    Am J Health Syst Pharm; 2013 Aug; 70(15):1272-4. PubMed ID: 23867482
    [No Abstract]   [Full Text] [Related]  

  • 29. [Two cases of Fanconi's syndrome induced by tenofovir in the Ivory Coast].
    Ondounda M; Tanon A; Ehui E; Ouattara I; Kassi A; Aba YT; Aoussi EF; Kakou AR; Eholié SP; Bissagnene E; Kadio A
    Med Mal Infect; 2011 Feb; 41(2):105-7. PubMed ID: 20832214
    [No Abstract]   [Full Text] [Related]  

  • 30. Tenofovir-induced renal tubular dysfunction presenting with hypocalcaemia.
    Williams J; Chadwick DR
    J Infect; 2006 Apr; 52(4):e107-8. PubMed ID: 16125779
    [No Abstract]   [Full Text] [Related]  

  • 31. Recurrent bone fractures due to tenofovir-induced renal phosphate wasting.
    Koenig KF; Kalbermatter S; Menter T; Graber P; Kiss D
    Scand J Infect Dis; 2014 Mar; 46(3):221-4. PubMed ID: 24147545
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proximal tubular kidney damage and tenofovir: a role for mitochondrial toxicity?
    Saumoy M; Vidal F; Peraire J; Sauleda S; Vea AM; Viladés C; Ribera E; Richart C
    AIDS; 2004 Aug; 18(12):1741-2. PubMed ID: 15280790
    [No Abstract]   [Full Text] [Related]  

  • 33. Tenofovir induced acute kidney injury in a patient with unilateral renal agenesis despite initially non-impaired renal function.
    Schleenvoigt BT; Stallmach A; Pletz MW
    Eur J Med Res; 2011 Dec; 16(12):564. PubMed ID: 22112365
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The use of biomarkers for assessing HAART-associated renal toxicity in HIV-infected patients.
    del Palacio M; Romero S; Casado JL
    Curr HIV Res; 2012 Sep; 10(6):521-31. PubMed ID: 22716111
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mitochondrial dysfunction and electron transport chain complex defect in a rat model of tenofovir disoproxil fumarate nephrotoxicity.
    Ramamoorthy H; Abraham P; Isaac B
    J Biochem Mol Toxicol; 2014 Jun; 28(6):246-55. PubMed ID: 24615786
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tenofovir-induced renal toxicity in 324 HIV-infected, antiretroviral-naïve patients.
    Calza L; Trapani F; Tedeschi S; Piergentili B; Manfredi R; Colangeli V; Viale P
    Scand J Infect Dis; 2011 Aug; 43(8):656-60. PubMed ID: 21453205
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [HIV infected women with intense bone and muscular pain and general weakness].
    Pérez-Rivera AÁ; Sáez P; León E; Lozano de León-Naranjo F
    Enferm Infecc Microbiol Clin; 2011 Apr; 29(4):308-10. PubMed ID: 21334782
    [No Abstract]   [Full Text] [Related]  

  • 38. Toward a pharmacogenetic understanding of nucleotide and nucleoside analogue toxicity.
    Hulgan T; Haas DW
    J Infect Dis; 2006 Dec; 194(11):1471-4. PubMed ID: 17083029
    [No Abstract]   [Full Text] [Related]  

  • 39. Renal tubular dysfunction associated with tenofovir therapy.
    Mitra S; Priscilla R; Rajeev K; Sauradeep S; Rajkumar S; Cherian AO
    J Assoc Physicians India; 2014 Jul; 62(7):580-2. PubMed ID: 25672029
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tenofovir-associated Fanconi syndrome in patients with chronic hepatitis B monoinfection.
    Gracey DM; Snelling P; McKenzie P; Strasser SI
    Antivir Ther; 2013; 18(7):945-8. PubMed ID: 23839869
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.